SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.13-0.1%Dec 18 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (51)7/24/1998 3:05:00 PM
From: scaram(o)uche  Read Replies (1) of 1475
 
"In fact, on a recent trip to New York and Boston, I learned that hedge funds are now shorting biotech stocks selling as low as
$4 a share,'' Fruedenthal said. ''These funds believe these stocks, even if they have good science, have no sponsorship and will
end up drifting down to the $1 a share range. These companies will find it impossible to get financing. They're orphans."

biz.yahoo.com

One can't be more orphaned than BTRN is orphaned. :-)

This, in my opinion, is a clear signal to find your favorite second- and third-tier companies and buy, buy, buy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News